CFD Research Welcomes Dan Shafer as Vice President of Test & Evaluation
CFD Research is pleased to announce the addition of Mr. Dan Shafer as Vice President of the Test & Evaluation (T&E) Division.
Delivering Breakthrough Solutions
CFD Research is pleased to announce the addition of Mr. Dan Shafer as Vice President of the Test & Evaluation (T&E) Division.
CFD Research Corporation is proud to announce that the University of Alabama in Huntsville (UAH) has appointed Professor George Nelson as the inaugural holder of the Ashok K. Singhal Endowed Chair in Mechanical and Aerospace Engineering.
CFD Research is developing next-generation programmable photonic circuits to help NASA reduce size, weight, power, and cost in future space systems.
CFD Research, a leader in advanced engineering solutions, has been awarded a contract by L3Harris Technologies (NYSE:LXH) in support of Next Generation Jammer – Low Band (NGJ-LB) Engineering and Manufacturing Development.
CFD Research has received a $1.25M Air Force contract to develop meta-optic technology that could reshape precision-guided weapons and advanced sensors for defense and commercial use.
The U.S. Space & Rocket Center and the Baron Critical Weather Institute have launched the “How We Know the Weather” exhibit, featuring an interactive Space Weather display sponsored by CFD Research that explores how solar activity impacts life on Earth.
CFD Research Corporation announced that its Engineering Test Center in Hollywood, AL, has achieved the AS9100 D/ISO 9001:2015 certification, reinforcing the company’s dedication to providing cutting-edge technologies and services in the aerospace and defense sectors.
CFD Research has been named the 2025 ESOP Company of the Year by the Southeast Chapter of the ESOP Association, a national organization dedicated to promoting employee ownership.
CFD Research has been awarded a $1.3M project by the U.S. Army to develop a multi-omics platform, revolutionizing diagnostics for PTSD, TBI, cancer, sepsis, and organ damage.
CFD Research has secured a competitive $1.6 million Grant from the NIH National Center for Complementary and Integrative Health (NCCIH). This significant achievement will provide nondilutive funding to advance the innovative Kalm Patch into clinical trials for the treatment of eczema and psoriasis.